ProShare Advisors
TDOC icon

ProShare Advisors’s Teladoc Health TDOC Stock Holding History

ProShare Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Sell
23,851
-1,953
-8% -$13K ﹤0.01% 1631
2026
Q1 		$141K Sell
25,804
-6,728
-21% -$37.7K ﹤0.01% 1661
2025
Q4 		$228K Buy
32,532
+2,457
+8% +$19.2K ﹤0.01% 1630
2025
Q3 		$232K Sell
30,075
-5,990
-17% -$46.8K ﹤0.01% 1612
2025
Q2 		$314K Sell
36,065
-1,201
-3% -$8.71K ﹤0.01% 1412
2025
Q1 		$297K Sell
37,266
-11,214
-23% -$113K ﹤0.01% 1419
2024
Q4 		$441K Buy
48,480
+16,312
+51% +$157K ﹤0.01% 1352
2024
Q3 		$295K Buy
+32,168
New +$266K ﹤0.01% 1478
2022
Q2 		– Sell
-3,676
Closed -$265K – 2106
2022
Q1 		$265K Sell
3,676
-345
-9% -$24.9K ﹤0.01% 1719
2021
Q4 		$369K Buy
4,021
+252
+7% +$30.1K ﹤0.01% 1657
2021
Q3 		$478K Sell
3,769
-979
-21% -$143K ﹤0.01% 1233
2021
Q2 		$790K Buy
4,748
+2,309
+95% +$374K ﹤0.01% 1185
2021
Q1 		$443K Buy
2,439
+225
+10% +$52.2K ﹤0.01% 1527
2020
Q4 		$443K Buy
2,214
+802
+57% +$163K ﹤0.01% 1343
2020
Q3 		$310K Buy
1,412
+210
+17% +$44.5K ﹤0.01% 1158
2020
Q2 		$229K Sell
1,202
-4,318
-78% -$757K ﹤0.01% 1386
2020
Q1 		$856K Sell
5,520
-6,000
-52% -$698K 0.01% 624
2019
Q4 		$964K Buy
11,520
+1,687
+17% +$128K ﹤0.01% 807
2019
Q3 		$666K Buy
9,833
+990
+11% +$65.2K ﹤0.01% 886
2019
Q2 		$587K Sell
8,843
-1,266
-13% -$73.8K ﹤0.01% 952
2019
Q1 		$562K Buy
10,109
+999
+11% +$61K ﹤0.01% 978
2018
Q4 		$452K Sell
9,110
-1,544
-14% -$94.5K ﹤0.01% 984
2018
Q3 		$920K Buy
10,654
+2,482
+30% +$177K 0.01% 858
2018
Q2 		$474K Buy
8,172
+747
+10% +$36.5K ﹤0.01% 1145
2018
Q1 		$299K Sell
7,425
-564
-7% -$21.3K ﹤0.01% 1325
2017
Q4 		$278K Buy
+7,989
New +$265K ﹤0.01% 1435

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

ProShare Advisors's TDOC Position: Q2 2026 in Review

ProShare Advisors reduced its Teladoc Health (TDOC) stake by 7.6% in Q2 2026, selling an estimated $13K and leaving 23,851 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

ProShare Advisors first reported a position in TDOC in Q4 2017 and has held it in 26 quarters since. The position peaked at $964K in Q4 2019. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • ProShare Advisors held 23,851 shares of Teladoc Health worth $202K as of Q2 2026.
  • ProShare Advisors sold 1,953 Teladoc Health shares in Q2 2026, an estimated $13K.
  • Teladoc Health made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1631 holding.
  • ProShare Advisors first reported a position in Teladoc Health in Q4 2017 and has held it in 26 quarters since.
  • ProShare Advisors's Teladoc Health position peaked at $964K in Q4 2019.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.